Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Scalable synthesis and structural characterization of reversible KLK6 inhibitors
Andreas Baumanna,
Daniel Isaka,
Jasmin Lohbecka,
Pravin Kumar Ankush Jagtapb,
Janosch Hennigbc and
Aubry K. Miller*ad
aCancer Drug Development Group, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. E-mail: aubry.miller@dkfz.de
bStructural and Computational Biology Unit, European Molecular Biology Laboratory (EMBL), 69117 Heidelberg, Germany
cChair of Biochemistry IV, Biophysical Chemistry, University of Bayreuth, 95447 Bayreuth, Germany
dGerman Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany
First published on 10th October 2022
Abstract
Correction for ‘Scalable synthesis and structural characterization of reversible KLK6 inhibitors’ by Andreas Baumann et al., RSC Adv., 2022, 12, 26989–26993, https://doi.org/10.1039/D2RA04670A.
The authors regret that incorrect details were given for note 20 in the original article. The correct version of note 20 is given below.
It appears as if compound 13, or more likely its enantiomer, was prepared in ref. 18 (personal communication with A. W. H. Speed).
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2022 |